These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 35014470)

  • 1. Dendrimer Architectonics to Treat Cancer and Neurodegenerative Diseases with Implications in Theranostics and Personalized Medicine.
    Moorthy H; Govindaraju T
    ACS Appl Bio Mater; 2021 Feb; 4(2):1115-1139. PubMed ID: 35014470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendrimer- and copolymer-based nanoparticles for magnetic resonance cancer theranostics.
    Ray S; Li Z; Hsu CH; Hwang LP; Lin YC; Chou PT; Lin YY
    Theranostics; 2018; 8(22):6322-6349. PubMed ID: 30613300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional Dendrimer-Entrapped Gold Nanoparticles Conjugated with Doxorubicin for pH-Responsive Drug Delivery and Targeted Computed Tomography Imaging.
    Zhu J; Wang G; Alves CS; Tomás H; Xiong Z; Shen M; Rodrigues J; Shi X
    Langmuir; 2018 Oct; 34(41):12428-12435. PubMed ID: 30251859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical studies of dendrimer prodrugs.
    Kojima C
    Expert Opin Drug Metab Toxicol; 2015; 11(8):1303-15. PubMed ID: 26028253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendrimers for theranostic applications.
    Sk UH; Kojima C
    Biomol Concepts; 2015 Jun; 6(3):205-17. PubMed ID: 26136305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theranostic Applications of Nanomaterials in Alzheimer's Disease: A Multifunctional Approach.
    Tripathi P; Shukla P; Bieberich E
    Curr Pharm Des; 2022; 28(2):116-132. PubMed ID: 34809540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics.
    Zhao Y; Houston ZH; Simpson JD; Chen L; Fletcher NL; Fuchs AV; Blakey I; Thurecht KJ
    Mol Pharm; 2017 Oct; 14(10):3539-3549. PubMed ID: 28880092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Albumin Carriers for Cancer Theranostics: A Conventional Platform with New Promise.
    Chen Q; Liu Z
    Adv Mater; 2016 Dec; 28(47):10557-10566. PubMed ID: 27111654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theranostic barcoded nanoparticles for personalized cancer medicine.
    Yaari Z; da Silva D; Zinger A; Goldman E; Kajal A; Tshuva R; Barak E; Dahan N; Hershkovitz D; Goldfeder M; Roitman JS; Schroeder A
    Nat Commun; 2016 Nov; 7():13325. PubMed ID: 27830705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotheranostics as personalized medicines.
    Kevadiya BD; Ottemann BM; Thomas MB; Mukadam I; Nigam S; McMillan J; Gorantla S; Bronich TK; Edagwa B; Gendelman HE
    Adv Drug Deliv Rev; 2019 Aug; 148():252-289. PubMed ID: 30421721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application and Importance of Theranostics in the Diagnosis and Treatment of Cancer.
    Jeyamogan S; Khan NA; Siddiqui R
    Arch Med Res; 2021 Feb; 52(2):131-142. PubMed ID: 33423803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-assembling dendrimer nanosystems for specific fluorine magnetic resonance imaging and effective theranostic treatment of tumors.
    Lyu Z; Ralahy B; Perles-Barbacaru TA; Ding L; Jiang Y; Lian B; Roussel T; Liu X; Galanakou C; Laurini E; Tintaru A; Giorgio S; Pricl S; Liu X; Bernard M; Iovanna J; Viola A; Peng L
    Proc Natl Acad Sci U S A; 2024 Jun; 121(25):e2322403121. PubMed ID: 38865273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyvalent Nanoobjects for Precision Diagnostics.
    Omstead DT; Sjoerdsma J; Bilgicer B
    Annu Rev Anal Chem (Palo Alto Calif); 2019 Jun; 12(1):69-88. PubMed ID: 30811215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimuli-Responsive Nanotheranostics for Real-Time Monitoring Drug Release by Photoacoustic Imaging.
    Yang Z; Song J; Tang W; Fan W; Dai Y; Shen Z; Lin L; Cheng S; Liu Y; Niu G; Rong P; Wang W; Chen X
    Theranostics; 2019; 9(2):526-536. PubMed ID: 30809290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic Nanoparticles in Cancer Theranostics.
    Gobbo OL; Sjaastad K; Radomski MW; Volkov Y; Prina-Mello A
    Theranostics; 2015; 5(11):1249-63. PubMed ID: 26379790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive approach of hybrid nanoplatforms in drug delivery and theranostics to combat cancer.
    Thorat ND; Townley HE; Patil RM; Tofail SAM; Bauer J
    Drug Discov Today; 2020 Jul; 25(7):1245-1252. PubMed ID: 32371139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Novel Dendrimer-Gold Complex Nanoparticles for Theranostic Application in Oncology.
    Milivojević N; Carvalho MR; Caballero D; Radisavljević S; Radoićić M; Živanović M; Kundu SC; Reis RL; Filipović N; Oliveira JM
    Nanomedicine (Lond); 2024 Mar; 19(6):483-497. PubMed ID: 38275157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomedicine for cancer diagnosis and therapy: advancement, success and structure-activity relationship.
    Bhise K; Sau S; Alsaab H; Kashaw SK; Tekade RK; Iyer AK
    Ther Deliv; 2017 Nov; 8(11):1003-1018. PubMed ID: 29061101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Glimpse into Dendrimers Integration in Cancer Imaging and Theranostics.
    Cruz A; Barbosa J; Antunes P; Bonifácio VDB; Pinto SN
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities.
    Ruman U; Fakurazi S; Masarudin MJ; Hussein MZ
    Int J Nanomedicine; 2020; 15():1437-1456. PubMed ID: 32184597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.